Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 42 of 1714:
32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
Gene Compound Assay Inh Ic50 Ki View
mu-opioid receptor MOR DANAZOL Opiate mu 69% 14.079uM 5.715uM View
Protein-tyrosine kinase, Fyn BETA-ESTRADIOL 3-BENZOATE Protein Tyrosine Kinase, Fyn 69% 22.994uM NoneNone View
sodium channel associated protein 2 AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
monoamine oxidase A BETA-NAPHTHOFLAVONE Monoamine Oxidase MAOA 69% NoneNone NoneNone View
monoamine oxidase A BETA-NAPHTHOFLAVONE Monoamine Oxidase MAOA 69% NoneNone NoneNone View
opioid receptor, sigma 1 METHAPYRILENE Sigma1 69% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 DIMENHYDRINATE Serotonin 5-HT6 69% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 MYCOPHENOLATE MOFETIL CYP450-3A4 Inhibition 69% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase PROCHLORPERAZINE CYP450-2C19 Inhibition 69% NoneNone NoneNone View
Sigma-2 Receptor BUFLOMEDIL Sigma2 69% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase 3,3',4',5-TETRACHLOROSALICYLANILIDE CYP450-1A2 Inhibition 69% NoneNone NoneNone View
acetylcholinesterase (YT blood group) FENBENDAZOLE Acetylcholinesterase 69% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase FENBENDAZOLE Acetylcholinesterase 69% NoneNone NoneNone View
acetylcholinesterase FENBENDAZOLE Acetylcholinesterase 69% NoneNone NoneNone View
sodium channel associated protein 1 DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel associated protein 2 DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B METHOXSALEN Serotonin 5-HT2B 66% NoneNone NoneNone View
adrenergic receptor, alpha 1a DIETHYLSTILBESTROL Adrenergic alpha1A 66% 19.487uM 7.888uM View
arachidonate 15-lipoxygenase, second type TYRPHOSTIN A23 Lipoxygenase 15-LO 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase TYRPHOSTIN A23 Lipoxygenase 15-LO 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase TYRPHOSTIN A23 Lipoxygenase 15-LO 66% NoneNone NoneNone View
thromboxane A synthase 1 DIETHYLSTILBESTROL Thromboxane Synthetase 66% 4.359uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) DIETHYLSTILBESTROL Thromboxane Synthetase 66% 4.359uM NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 DIETHYLSTILBESTROL Adenosine Transporter 66% 14.126uM 4.833uM View
concentrative Na+ nucleoside cotransporter (DBSS) DIETHYLSTILBESTROL Adenosine Transporter 66% 14.126uM 4.833uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 DIETHYLSTILBESTROL Adenosine Transporter 66% 14.126uM 4.833uM View
adenine nucleotide translocase (DBSS) (Non-specific probe) DIETHYLSTILBESTROL Adenosine Transporter 66% 14.126uM 4.833uM View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 DIETHYLSTILBESTROL Adenosine Transporter 66% 14.126uM 4.833uM View
5-hydroxytryptamine (serotonin) receptor 2B NOCODAZOLE Serotonin 5-HT2B 66% 20.18uM 12.845uM View
androgen receptor MESTRANOL Testosterone 66% 10.682uM 7.121uM View
Cytochrom P450-1A2 monooxygenase BUTAMBEN CYP450-1A2 Inhibition 66% NoneNone NoneNone View
opioid receptor, sigma 1 TESTOSTERONE Sigma1 66% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) ISOPRENALINE Adrenergic alpha1D 66% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 ALPHA-NAPHTHOFLAVONE Muscarinic M4 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 AMLODIPINE Calcium Channel Type L, Phenylalkylamine 66% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) U-78517F Protein Tyrosine Kinase, Lck 66% 17.137uM NoneNone View
epidermal growth factor receptor TRETINOIN Protein Tyrosine Kinase, EGF Receptor 66% NoneNone NoneNone View
protein tyrosine phosphatase, receptor type, C COLISTIN Protein Tyrosine Phosphatase, CD45 66% NoneNone NoneNone View
protein tyrosine phosphatase, receptor type, C COLISTIN Protein Tyrosine Phosphatase, CD45 66% NoneNone NoneNone View
adrenergic receptor, beta 1 EPINEPHRINE Adrenergic beta1 66% NoneNone NoneNone View
adrenergic, beta-1-, receptor EPINEPHRINE Adrenergic beta1 66% NoneNone NoneNone View
adenosine A1 receptor NIFEDIPINE Adenosine A1 66% 7.701uM 4.492uM View
cannabinoid receptor 1 (brain) CLEMASTINE Cannabinoid CB1 66% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 TETRACAINE Muscarinic M5 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type THIOGUANINE Lipoxygenase 15-LO 66% 16.159uM NoneNone View
arachidonate 15-lipoxygenase THIOGUANINE Lipoxygenase 15-LO 66% 16.159uM NoneNone View
arachidonate 15-lipoxygenase THIOGUANINE Lipoxygenase 15-LO 66% 16.159uM NoneNone View
adrenergic receptor, alpha 2a DEXTROMETHORPHAN Imidazoline I2, Central 66% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) DEXTROMETHORPHAN Imidazoline I2, Central 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, gamma subunit 6 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, gamma subunit 5 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, gamma subunit 4 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, gamma subunit 3 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, gamma subunit 2 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, gamma subunit 1 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, beta 4 subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, beta 3 subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, beta 2 subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, alpha 1F subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, beta 1 subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
calcium channel, voltage-dependent, gamma subunit 8 SIBUTRAMINE Calcium Channel Type L, Phenylalkylamine 70% 2.722uM 2.647uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 PROPOFOL Adrenergic, Norepinephrine Transporter 70% 9.393uM 9.316uM View
matrix metalloproteinase 1 (interstitial collagenase) NIMESULIDE Protease, Matrix Metalloprotease-1 (MMP-1) 70% 23.345uM NoneNone View
adenosine A2a receptor NISOLDIPINE Adenosine A2A 70% 4.058uM 2.278uM View
chemokine (C-C motif) receptor 2 BAY 11-7085 Chemokine CCR2B 70% 4.177uM 1.614uM View
histamine receptor H 2 FAMOTIDINE Histamine H2 70% .042uM .041uM View
histamine receptor H 1 DROPERIDOL Histamine H1, Central 70% 4.519uM .525uM View
adrenergic receptor, alpha 1a EMETINE Adrenergic alpha1A 70% 6.527uM 2.642uM View
calcium channel, voltage-dependent, gamma subunit 8 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, gamma subunit 7 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, gamma subunit 6 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, gamma subunit 5 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, gamma subunit 4 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, gamma subunit 3 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, gamma subunit 2 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, gamma subunit 1 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, beta 4 subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, beta 3 subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, beta 2 subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, alpha 1F subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, beta 1 subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
sodium channel, nonvoltage-gated 1 alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DIPHENIDOL Sodium Channel, Site 2 69% NoneNone NoneNone View
adrenergic receptor, alpha 1b METHYLERGONOVINE Adrenergic alpha1B 69% NoneNone NoneNone View
adrenergic receptor, beta 1 METHYLERGONOVINE Adrenergic beta1 69% NoneNone NoneNone View
adrenergic, beta-1-, receptor METHYLERGONOVINE Adrenergic beta1 69% NoneNone NoneNone View
adrenergic receptor, alpha 2b CLONIDINE Adrenergic alpha2C 69% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) CLONIDINE Adrenergic alpha2C 69% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type NELFINAVIR Lipoxygenase 15-LO 69% 13.797uM NoneNone View
arachidonate 15-lipoxygenase NELFINAVIR Lipoxygenase 15-LO 69% 13.797uM NoneNone View
arachidonate 15-lipoxygenase NELFINAVIR Lipoxygenase 15-LO 69% 13.797uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, gamma subunit 7 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, gamma subunit 6 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, gamma subunit 5 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, gamma subunit 4 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, gamma subunit 3 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, gamma subunit 2 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, gamma subunit 1 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
adrenergic receptor, alpha 2a CLEMASTINE Imidazoline I2, Central 68% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) CLEMASTINE Imidazoline I2, Central 68% NoneNone NoneNone View
epidermal growth factor receptor FLUORESCEIN Protein Tyrosine Kinase, EGF Receptor 68% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A CAFFEIC ACID PHENETHYL ESTER Serotonin 5-HT2A 68% NoneNone NoneNone View
A3 adenosine receptor DICUMAROL Adenosine A3 68% NoneNone NoneNone View
adenosine A1 receptor GENISTEIN Adenosine A1 68% 19.904uM 11.611uM View
monoamine oxidase A HYDRALAZINE Monoamine Oxidase MAOA 68% NoneNone NoneNone View
monoamine oxidase A HYDRALAZINE Monoamine Oxidase MAOA 68% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B GENTIAN VIOLET Serotonin 5-HT2B 68% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A GUANFACINE Serotonin 5-HT1A 68% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase OXICONAZOLE CYP450-1A2 Inhibition 68% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 1-NAPHTHYL ISOTHIOCYANATE Chemokine CCR2B 68% 6.699uM 2.589uM View
calcium channel, voltage-dependent, gamma subunit 8 ITRACONAZOLE Calcium Channel Type L, Benzothiazepine 68% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 ITRACONAZOLE Calcium Channel Type L, Benzothiazepine 68% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 ITRACONAZOLE Calcium Channel Type L, Benzothiazepine 68% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 ITRACONAZOLE Calcium Channel Type L, Benzothiazepine 68% NoneNone NoneNone View